19-35249054-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_205834.4(LSR):c.32G>A(p.Gly11Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,582,216 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_205834.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LSR | NM_205834.4 | c.32G>A | p.Gly11Glu | missense_variant | 1/10 | ENST00000605618.6 | NP_991403.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LSR | ENST00000605618.6 | c.32G>A | p.Gly11Glu | missense_variant | 1/10 | 1 | NM_205834.4 | ENSP00000474797 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152100Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000329 AC: 6AN: 182196Hom.: 0 AF XY: 0.0000299 AC XY: 3AN XY: 100444
GnomAD4 exome AF: 0.0000196 AC: 28AN: 1430000Hom.: 0 Cov.: 31 AF XY: 0.0000183 AC XY: 13AN XY: 709048
GnomAD4 genome AF: 0.000151 AC: 23AN: 152216Hom.: 1 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2023 | The c.176G>A (p.G59E) alteration is located in exon 1 (coding exon 1) of the LSR gene. This alteration results from a G to A substitution at nucleotide position 176, causing the glycine (G) at amino acid position 59 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at